CIBC Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44.3M | Buy |
1,840,616
+46,953
| +3% | +$1.23M | 0.1% | 151 |
|
|
2026
Q1 | $50.4M | Buy |
1,793,663
+208,006
| +13% | +$5.54M | 0.12% | 127 |
|
|
2025
Q4 | $39.5M | Buy |
1,585,657
+525,025
| +50% | +$13.2M | 0.1% | 155 |
|
|
2025
Q3 | $27M | Buy |
1,060,632
+25,290
| +2% | +$624K | 0.08% | 161 |
|
|
2025
Q2 | $25.1M | Sell |
1,035,342
-47,429
| -4% | -$1.11M | 0.08% | 174 |
|
|
2025
Q1 | $27.4M | Buy |
1,082,771
+14,732
| +1% | +$385K | 0.09% | 152 |
|
|
2024
Q4 | $28.3M | Buy |
1,068,039
+2,701
| +0.3% | +$73.3K | 0.09% | 146 |
|
|
2024
Q3 | $30.8M | Buy |
1,065,338
+61,988
| +6% | +$1.81M | 0.1% | 137 |
|
|
2024
Q2 | $28.1M | Sell |
1,003,350
-892,648
| -47% | -$24.6M | 0.1% | 137 |
|
|
2024
Q1 | $52.6M | Buy |
1,895,998
+3,942
| +0.2% | +$109K | 0.18% | 97 |
|
|
2023
Q4 | $54.5M | Sell |
1,892,056
-117,448
| -6% | -$3.55M | 0.2% | 85 |
|
|
2023
Q3 | $66.7M | Buy |
2,009,504
+39,946
| +2% | +$1.41M | 0.28% | 70 |
|
|
2023
Q2 | $72.2M | Buy |
1,969,558
+215,373
| +12% | +$8.38M | 0.28% | 71 |
|
|
2023
Q1 | $71.6M | Buy |
1,754,185
+128,999
| +8% | +$5.57M | 0.28% | 70 |
|
|
2022
Q4 | $83.3M | Buy |
1,625,186
+43,150
| +3% | +$2.07M | 0.35% | 55 |
|
|
2022
Q3 | $69.2M | Buy |
1,582,036
+836,997
| +112% | +$40.7M | 0.3% | 63 |
|
|
2022
Q2 | $39.1M | Buy |
745,039
+34,734
| +5% | +$1.77M | 0.16% | 95 |
|
|
2022
Q1 | $36.8M | Buy |
710,305
+56,462
| +9% | +$2.93M | 0.13% | 106 |
|
|
2021
Q4 | $38.6M | Sell |
653,843
-186,468
| -22% | -$9.24M | 0.14% | 102 |
|
|
2021
Q3 | $36.1M | Sell |
840,311
-119,747
| -12% | -$5.3M | 0.15% | 104 |
|
|
2021
Q2 | $37.6M | Sell |
960,058
-2,454
| -0.3% | -$95.4K | 0.15% | 102 |
|
|
2021
Q1 | $34.9M | Buy |
962,512
+41,359
| +4% | +$1.47M | 0.15% | 105 |
|
|
2020
Q4 | $33.9M | Sell |
921,153
-94,911
| -9% | -$3.48M | 0.16% | 105 |
|
|
2020
Q3 | $35.4M | Buy |
1,016,064
+28,813
| +3% | +$1.01M | 0.18% | 96 |
|
|
2020
Q2 | $30.6M | Buy |
987,251
+240,252
| +32% | +$8.16M | 0.18% | 81 |
|
|
2020
Q1 | $23.1M | Sell |
746,999
-16,845
| -2% | -$574K | 0.16% | 91 |
|
|
2019
Q4 | $28.4M | Buy |
763,844
+46,305
| +6% | +$1.65M | 0.16% | 74 |
|
|
2019
Q3 | $24.5M | Buy |
717,539
+107,800
| +18% | +$3.92M | 0.14% | 78 |
|
|
2019
Q2 | $25.1M | Buy |
609,739
+17,449
| +3% | +$693K | 0.15% | 72 |
|
|
2019
Q1 | $23.9M | Buy |
592,290
+7,554
| +1% | +$303K | 0.15% | 72 |
|
|
2018
Q4 | $24.2M | Sell |
584,736
-66,419
| -10% | -$2.76M | 0.18% | 64 |
|
|
2018
Q3 | $27.2M | Buy |
651,155
+5,083
| +0.8% | +$196K | 0.17% | 64 |
|
|
2018
Q2 | $22.2M | Buy |
646,072
+40,490
| +7% | +$1.38M | 0.14% | 75 |
|
|
2018
Q1 | $20.4M | Sell |
605,582
-29,720
| -5% | -$1.02M | 0.13% | 77 |
|
|
2017
Q4 | $21.8M | Sell |
635,302
-393,794
| -38% | -$13.4M | 0.13% | 76 |
|
|
2017
Q3 | $34.9M | Sell |
1,029,096
-17,558
| -2% | -$564K | 0.22% | 54 |
|
|
2017
Q2 | $33.4M | Sell |
1,046,654
-3,925
| -0.4% | -$124K | 0.23% | 53 |
|
|
2017
Q1 | $34.1M | Sell |
1,050,579
-1,672
| -0.2% | -$52.7K | 0.23% | 52 |
|
|
2016
Q4 | $32.4M | Buy |
1,052,251
+12,504
| +1% | +$382K | 0.23% | 52 |
|
|
2016
Q3 | $33.4M | Sell |
1,039,747
-28,905
| -3% | -$967K | 0.25% | 48 |
|
|
2016
Q2 | $35.7M | Buy |
1,068,652
+489
| +0% | +$15.6K | 0.27% | 49 |
|
|
2016
Q1 | $30M | Sell |
1,068,163
-64,032
| -6% | -$1.83M | 0.23% | 54 |
|
|
2015
Q4 | $34.7M | Sell |
1,132,195
-84,049
| -7% | -$2.64M | 0.29% | 45 |
|
|
2015
Q3 | $36.2M | Buy |
1,216,244
+538,624
| +79% | +$17.3M | 0.29% | 41 |
|
|
2015
Q2 | $21.6M | Buy |
677,620
+24,168
| +4% | +$788K | 0.15% | 70 |
|
|
2015
Q1 | $21.6M | Buy |
653,452
+5,836
| +0.9% | +$186K | 0.15% | 63 |
|
|
2014
Q4 | $19.1M | Sell |
647,616
-146,885
| -18% | -$4.21M | 0.13% | 69 |
|
|
2014
Q3 | $22.3M | Sell |
794,501
-53,289
| -6% | -$1.5M | 0.13% | 66 |
|
|
2014
Q2 | $23.9M | Buy |
847,790
+1,004
| +0.1% | +$28.6K | 0.14% | 69 |
|
|
2014
Q1 | $25.8M | Buy |
846,786
+7,398
| +0.9% | +$221K | 0.15% | 65 |
|
|
2013
Q4 | $24.4M | Sell |
839,388
-55,137
| -6% | -$1.6M | 0.15% | 63 |
|
|
2013
Q3 | $24.4M | Sell |
894,525
-2,770
| -0.3% | -$75.4K | 0.16% | 60 |
|
|
2013
Q2 | $23.8M | Buy |
+897,295
| New | +$24.8M | 0.16% | 60 |
|
Other funds holding PFE
CIBC Asset Management's PFE Position: Q2 2026 in Review
CIBC Asset Management increased its Pfizer (PFE) stake by 2.6% in Q2 2026, buying an estimated $1.23M and bringing the position to 1,840,616 shares worth $44.3M. The position accounts for 0.1% of the portfolio, ranked #151.
CIBC Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $83.3M in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- CIBC Asset Management held 1,840,616 shares of Pfizer worth $44.3M as of Q2 2026.
- CIBC Asset Management bought 46,953 Pfizer shares in Q2 2026, an estimated $1.23M.
- Pfizer made up 0.1% of CIBC Asset Management's portfolio in Q2 2026, its #151 holding.
- CIBC Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- CIBC Asset Management's Pfizer position peaked at $83.3M in Q4 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.